Design Therapeutics
Solana Beach
About Design Therapeutics
Design Therapeutics is a biotechnology company developing a new class of therapies for serious degenerative disorders caused by nucleotide repeat expansions. The company’s lead program is focused on the treatment of Friedreich’s ataxia and discovery efforts are ongoing in other degenerative diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $170.7M
- Funding stage: IPO
- Last round: Series B (Jan 2021)
- Ticker: nasdaq:DSGN
- Website: designtx.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Life Science, Medical
Social Profiles
Canonical: https://fsome.com/organization/design-therapeutics-25756 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.